Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.

Brain : a journal of neurology - 1 Jan 2014

Lim Yen Ying, Maruff Paul, Pietrzak Robert H, Ames David, Ellis Kathryn A, Harrington Karra, Lautenschlager Nicola T, Szoeke Cassandra, Martins Ralph N, Masters Colin L, Villemagne Victor L, Rowe Christopher C

Abstract excerpt

High amyloid has been associated with substantial episodic memory decline over 18 and 36 months in healthy older adults and individuals with mild cognitive impairment. However, the nature and magnitude of amyloid-related memory and non-memory change from the preclinical to the clinical stages of Alzheimer's disease has not been evaluated over the same time interval. Healthy older adults (n = 320), individuals...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Data Interpretation, Statistical

Share to Life Style

Share to Memory

Share to Neuropsychological Tests

Share to Positron-Emission Tomography

Source

Identifiers

PMID: 24176981
DOI: 10.1093/brain/awt286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.PMID 24176981Read ↗

APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.Semantic proximity Read ↗

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.Semantic proximity Read ↗

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.Semantic proximity Read ↗

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.Semantic proximity Read ↗

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without DementiaSemantic proximity Read ↗

A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.Semantic proximity Read ↗

Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.Semantic proximity Read ↗

Mild cognitive impairment--an early stage of Alzheimer's disease?Semantic proximity Read ↗

Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.Semantic proximity Read ↗

Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline.Semantic proximity Read ↗

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.